Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 27, Issue 2, 2009, Pages 260-266

  Kawasaki, M ^a   Sekigawa, I ^a,b   Nozawa, K ^b   Kaneko, H ^b   Takasaki, Y ^c   Takamori, K ^a   Ogawa, H ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA microarray; Menstrual cycle; Sex hormone; SIRPG; Systemic lupus erythematosus; TNFRSFI4

Indexed keywords

ESTRADIOL; PREDNISOLONE; PROGESTERONE; REGULATOR PROTEIN; SINGLE REGULATORY PROTEIN GAMMA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; ESTRADIOL BLOOD LEVEL; FEMALE; GENDER BIAS; GENE; GENE EXPRESSION; HUMAN; INCIDENCE; MALE; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, DIFFERENTIATION; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENSTRUAL CYCLE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SEX FACTORS; UP-REGULATION;

EID: 67249084871     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. LOCKSHIN MD: Sex ratio and rheumatic disease: excepts from an institute of medicine report. Lupus 2002; 11: 662-6.
2. øSTENSEN M: Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann NY Acad Sci 1991; 876: 131-43.
3. SEKIGAWA 1, NAITO T, HIRA K et al.: Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 2004; 13: 217-22.
4. CUTOLO M, SULLI A, VILLAGGIO B et al.: Relationships between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1998; 57: 573-7.
5. VERTHELYI D: Sex hormones as immunomodulators in health and disease. Int immunopharmacol 2001; 1: 983-93.
6. TAN EN, COHEN AS, FRIES JF et at.: The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum 1982; 25: 1271-7.
7. BOMBARDIEER C, GLADMAN DD, UROWITZ MB et at.: Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35: 630-40.
8. JOHNSON MR. CARTER G, GRINT C et at.: Relationship between ovarian steroids, gonadotropins and relaxin during the menstrual cycle. Acta Endcrinot 1993; 129: 12 1-5.
9. FUKUHARA Y, HIRASAWA A, LI XK et at.: Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatot 2003; 38: 784-92.
10. KAWASAKI M. KANEDA K. KANEKO H et at.: Two cases of dermatomyositis associated with interstitial pneumonia: Comprehensive study of gene expression. Clin Exp Rheumatot 2008; 26: 379-80.
11. NORTON SD, HARRISON LL. YOWELL R et at.: Administration of dehydroepiandroster one sulfate retards Onset but not progression of autoimmune disease in NZB/W mice. Autoimmunity 1997; 26: 161-71.
12. VERTHELYI D, ANSAR AHMED S: Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cett linmunot 1998; 18: 125-34.
13. CASOLI F, TUMAKI B. LA SALA G: Fatal exacerbation of SLE after induction of ovulation. J Rheumatol 1997: 24: 1640.
14. KANDA N. TAMAKI K: Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Ctin bnmunol 1999; 103: 282-8.
15. VERTHELYI D. KLINMAN DM: Sex hormone levels correlate with the activity of cytokinesecreting cells in viva. Immunotogy 2000; 10: 384-90.
16. CHADHA S. MILLER K, FARWELL L et at.: Haplotype analysis of tumor necrosis factor receptor genes in lp36: no evidence for association with systemic lupus erythematosus. Eur J Hum Genet 2006; 14: 69-78.
17. JUNG HW. LA SJ. KIM JK et at.: High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp Mat Med 2003: 35: 501-8.
18. WANG J, LO JC, FOSTER A et at.: The regulation of T-cell homeostasis and autoimmunity by T cell-derived LIGHT. J Ctin Invest 2001; 108: 1771-80.
19. WANG J. FU XY: The role of Light in T cell- mediated immunity. Immunot Rev 2004: 30: 201-14.
20. WATTS TH: TNF/TNFR family members in costimulation of T cell responses. Ann Rev Imniunol 2005; 23: 23-68.
21. SEDY JR. GAVRIELI M. POTITTERKG et at.: B and T lymphocyte attenuator regulated T cell activation through interaction with herpesvirus entry mediator. Nat Inzmwiol 2004: 6: 90-7.
22. BARCLAY AN. BROWN NIH: The SIRP family of receptors and immune regulation. Nat Iminunol 2006: 6: 457-64.
23. BROOKE G. HOLBROOK JD. BROWN MH et at.: Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) famil). J Immunol 2004: 173: 2562-70.
24. OLSSON M, NILSSON A, OLDENBORG PA: Target cell CD47 regulates macrophage activation and erythrophagocytosis. Transfus Clin Biol 2006: 13: 39-43.
25. INUI A. OGASAWARA H, NAITO T et at.: Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 2007: 26: 1675-8.